Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,411 public trials 1,032 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Active, Not Recruiting

Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax

NCT05222984

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

NCT05020678

Conditions: Aggressive Lymphoma, B-cell Acute Lymphoblastic Leukemia, Blood Protein Disorders, +43 more
Locations: Colorado Blood Cancer Institute Denver, Colorado, United States

The Cleveland Clinic Foundation Cleveland, Ohio, United States

Institute of Haematology, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia

St. Vincent's Hospital Sydney, New South Wales, Australia

View Trial Details

Active, Not Recruiting

Epidemiological Study of Korean Radiation Workers

NCT05380570

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +8 more
Locations: Korea Institute of Radiological & Medical Sciences Seoul, Nowon-gu, South Korea

View Trial Details

Active, Not Recruiting

Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers

NCT07162181

Conditions: B-cell Lymphoma, Chronic Disease, Disease Attributes, +17 more
Locations: Beijing Cancer hospital Beijing, China

Sun Yat-sen University Cancer Center Guangzhou, China

Harbin Medical University Cancer Hospital Harbin, China

Shanghai East Hospital Shanghai, China

View Trial Details

Active, Not Recruiting

Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia

NCT02131584

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction Chemotherapy

NCT05456698

Conditions: Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Active, Not Recruiting

Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT02250937

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia

NCT01424982

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, +28 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory Leukemia

NCT03132454

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL

NCT02514083

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Leukemia

Leukemia trial results

Related conditions